qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma (Q44307668)

1 December 2017

title

qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma (English)

1 reference

Fluorodeoxyglucose Positron Emission Tomography

1 December 2017

main subject

1 reference

13

Alexander Fosså

1 reference

1 December 2017

Christine Mauz-Körholz

3

object named as

Christine Mauz-Körholz

1 reference

1 December 2017

Dirk Hasenclever

1

1 reference

1 December 2017

Lars Kurch

2

1 reference

1 December 2017

Andreas Elsner

4

1 reference

1 December 2017

Thomas Georgi

5

1 reference

1 December 2017

Hamish Wallace

6

1 reference

1 December 2017

Judith Landman-Parker

7

1 reference

1 December 2017

Angelina Moryl-Bujakowska

8

1 reference

1 December 2017

Michaela Cepelová

9

1 reference

1 December 2017

Jonas Karlén

10

1 reference

1 December 2017

Ana Álvarez Fernández-Teijeiro

11

1 reference

1 December 2017

Andishe Attarbaschi

12

1 reference

1 December 2017

Jane Pears

14

1 reference

1 December 2017

Andrea Hraskova

15

1 reference

1 December 2017

Eva Bergsträsser

16

1 reference

1 December 2017

Auke Beishuizen

17

1 reference

1 December 2017

Anne Uyttebroeck

18

1 reference

1 December 2017

Eckhard Schomerus

19

1 reference

1 December 2017

Osama Sabri

20

1 reference

1 December 2017

Dieter Körholz

21

1 reference

1 December 2017

Regine Kluge

22

1 reference

1 December 2017

publication date

7 March 2014

1 reference

1 December 2017

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

1 December 2017

volume

41

1 reference

1 December 2017

issue

7

1 reference

1 December 2017

page(s)

1301-1308

1 reference

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas--the PETAL trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Importance of F18-Fluorodeoxy-D-2-Glucose Positron Emission Tomography (FDG-PET) for Staging and Therapy Control of Hodgkin’s Lymphoma in Childhood and Adolescence – Consequences for the GPOH-HD 2003 Protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

[Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Interim 18F-FDG PET in Hodgkin lymphoma: would PET-adapted clinical trials lead to a paradigm shift?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8–9 April 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Measuring response with FDG-PET: methodological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma--results for dedicated assessment criteria in a blinded dual-centre read.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

Comparison of various criteria in interpreting end of therapy F-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography in patients with aggressive non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2715-9

PET positive, PET negative, or PET peeve?

21 January 2018

1 reference

12 December 2020

Interim PET in lymphoma: a step towards standardization

1 reference

12 December 2020

Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

1 reference

12 December 2020

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.

1 reference

12 December 2020

Early interim FDG PET/CT prediction of treatment response and prognosis in pediatric Hodgkin disease-added value of low-dose CT

1 reference

12 December 2020

The EuroNet paediatric hodgkin network - modern imaging data management for real time central review in multicentre trials

1 reference

12 December 2020

Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues

1 reference

12 December 2020

18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation

1 reference

12 December 2020

SUV: standard uptake or silly useless value?

1 reference

12 December 2020

10.1007/S00259-014-2715-9

Identifiers

DOI

1 reference

1 December 2017

1 reference